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Abstract
Osteoarthritis (OA) is a degenerative joint disease and a leading
cause of adult disability. While joint replacement surgery is a common
treatment option for end-stage disease, non-surgical management is
critical for preventing disability and maintaining quality of life. Although
therapeutic ultrasound, which applies mechanical and may also apply
thermal energy in the form of sound waves, is widely used to treat
various musculoskeletal disorders such as bone fractures, tendinopathy,
and muscle contusions, its symptom- and disease-modifying effects
on osteoarthritis have not been clearly demonstrated. Recent clinical
evidence indicates therapeutic ultrasound is capable of relieving OAassociated pain and improving function of diseased joints. Furthermore,
in vitro and in vivo studies are beginning to emerge which suggest
ultrasound may exert chondroprotection, such as enhancing anabolic
activity, suppressing proteolytic enzyme-mediated degradation of the
cartilage matrix, preventing chondrocyte apoptosis and modifying
the endocrinology of adipose tissue that may potentially contribute to
OA disease initiation and progression. Therefore, ultrasound may have
great potential to serve as an effective and non-invasive therapeutic
treatment for osteoarthritis.

Introduction
Osteoarthritis (OA) affects over 27 million Americans, is a
leading cause of pain and disability [1,2], and is a significant economic
burden in the United States with over $185.5 billion in annual
medical care expenditures [3]. While OA is a disease of the entire
synovial joint, and affects the underlying bone, synovium, meniscus,
ligaments/tendons, and articular cartilage [4,5], erosion of articular
cartilage is the pathological hallmark of osteoarthritis, and cartilage
is a major target for exploring disease-modifying treatment [4,6-8].
Cartilage lines the ends of the bones, allowing for the articulation of
opposing joint surfaces. Destruction of articular cartilage leads to
bone-on-bone contact, causing stiffness, pain, and ultimately, loss of
movement in the joints [9].
There is currently no cure for OA. Therapies, which mainly
address OA-related symptoms such as pain and dysfunction, have
no demonstrated effect on slowing or arresting its progression [6,10].
End-stage disease often requires surgical intervention such as a total
joint replacement. At earlier stages of OA, however, non-surgical
management is critical for preventing disability and maintaining
quality of life. Non-pharmacologic interventions, including
mechanical-based therapies, are commonly recommended to OA
patients [11].
Recent clinical trials show therapeutic ultrasound such as low-
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intensity ultrasound can improve OA-associated pain and dysfunction
[12], although its effects in modifying disease progression require to
be further studied. In this review, we will first provide a brief overview
regarding the concept of therapeutic ultrasound and its current use
in musculoskeletal tissue repair and disorders. We will then discuss
recent clinical evidence of ultrasound in modifying OA-associated
symptoms and mechanisms-based evidence that supports the concept
of using ultrasound in chondroprotection and OA treatment.

Therapeutic Ultrasound and its Use in Musculoskeletal
Tissue Repair and Disorders
Therapeutic ultrasound treatment, such as those using lowintensity ultrasound wave energy, are widely used to treat pain and
various musculoskeletal disorders including bone fractures, shoulder
pain, pressure ulcers, and muscle soreness [13]. Upon penetrating
the biological tissue, these low-intensity ultrasound waves generate
acoustic vibrations that cause local movement of cell membrane, fluid
and macromolecules [14]. This produces mechanical stimulation
that subsequently changes the physical and biological properties of
the cells, such as cell membrane permeability, fluid movement and
exchange of intracellular and extracellular ions, all of which eventually
alter cell growth and metabolism [15].
The actual biological effect of ultrasound therapy varies with
the energy that is delivered to the tissue. The energy of ultrasound
is expressed as sonic intensity (SI: W/cm2) that is proportional to
sonic pressure square. Low-intensity ultrasound uses ultrasound with
intensities less than 3W/cm2 and is usually used as physiotherapy to
stimulate cell proliferation and tissue repair [15]. On the contrary,
high-intensity ultrasound approaches use focused ultrasound probes
that concentrate the wave energy in a smaller tissue region, reaching
intensities higher than 5 W/cm2, which can cause coagulative
necrosis of tissues due to thermal absorption, and is normally used
as an ablative agent to destroy target tissues [16]. Depending on the
energy and way the ultrasound is delivered, the biophysical effects
of ultrasound are traditionally separated into thermal and nonthermal effects. Thermal effects are caused by vibration or rotation
of macromolecules in the tissue, which result in frictional heat and
a rise in temperature. Non-thermal effects are characterized by the
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formation of tiny gas bubbles (stable cavitation) and the movement
of liquid around the vibrating bubbles (acoustic streaming) in the
tissue. Heat increases are predominately observed in tissues exposed
to continuous high intensity ultrasound. In tissues treated with lowintensity pulsed ultrasound (LIPUS), the non-thermal effects are
dominant [15].
The most common use of therapeutic ultrasound is for the
facilitation of bone fracture healing. In 1983, LIPUS was found to heal
70% of non-unions in patients with lower extremity fractures [17].
Eleven years later, a randomized double-blinded controlled study was
conducted by Heckman et al. [18]. Among 67 patients with closed or
grade-I open fractures of the tibial shaft, 33 received LIPUS treatment
and the average healing time in these patients was significantly
decreased when compared with controls (86 vs. 114 days). Consistent
with these results, another multicenter, prospective, randomized,
double-blind and placebo-controlled clinical trial revealed significant
acceleration of dorsal radius fracture healing in patients treated with
LIPUS (61 vs. 98 days) [19]. In a large-scale efficacy assessment,
successful healing rates of LIPUS in the treatment of delayed unions
and non-unions were 91% and 86%, respectively [20].
Ultrasound is also used to treat tendon conditions such as
tendinopathy and tendonitis [21,22]. In vitro studies demonstrate
ultrasound enhances the proliferation and migration of tendonreparative cells, and collagen synthesis in tendon cells, suggesting
it may improve tendon healing [23]. In animal models of Achilles
tendon rupture, daily ultrasound accelerated the healing process [24],
and improved collagen alignment and mechanical strength in healing
tendons compared to untreated controls [25]. However, clinical trials
so far have not clearly demonstrated that therapeutic ultrasound
improves treatment outcomes in tendon conditions such as patellar
tendinopathy [22], but may accelerate the initial phase of the tendonbone healing process after rotator cuff repair [26].
Experimental evidence supporting the use of therapeutic
ultrasound for skeletal muscle contusions is mixed. Ultrasound pulses
(1.5 W/cm2, 20% duty cycle, 3MHz frequency) applied to 12 adult
female Sprague-Dawley rats with experimental right calf contusion
injury resulted in significant satellite cell proliferation in the early
phase of muscle regeneration [27]. However, the overall effect of
ultrasound therapy on muscle regeneration was not significant due
to unaffected recapillarization and myotube production. Studies by
Karnes et al. revealed that continuous ultrasound therapy improved
force production of injured muscle 7 days after injury [28]. Two
subsequent randomized controlled trials of 100 male Wistar rats
with contusion muscle injury found no evidence to support the effect
of ultrasound therapy on muscle regeneration [29,30]. However,
one recent study suggests LIPUS can enhance the regeneration
of myofibers in both in vitro and in vivo muscle laceration models
[31]. While these findings suggest ultrasound could improve muscle
injury outcomes, more studies are needed to evaluate its therapeutic
efficacies.

OA-Symptom Modification
Joint pain and dysfunction are two major symptoms that OA
patients experience. A systemic review with meta-analysis compared
outcomes including joint pain and function in six controlled trials
where OA patients received ultrasound or a sham treatment [12].
In all six studies, ultrasound was applied at a 1 MHz frequency, but
with varying intensities and dosing schedules. Overall, low-intensity
J Surgery 1(2): 5 (2013)

pulsed ultrasound at doses < 150 Joules/cm2 significantly reduced
patient-reported pain using a Visual Analog Scale (VAS) [Standard
mean difference (Confidence Interval) = -0.49 (-0.79, -0.18), P =
0.002]. Self-reported function with the Lequesne index or WOMAC
(Western Ontario and McMaster Universities Arthritis Index) score
showed ultrasound intervention generally led to improvements
in function, although differences were not statistically significant.
Two of these studies monitored adverse events, and both reported
no major complications. This review [12] concluded that ultrasound
appears to be effective in decreasing OA-associated pain, and
may improve function in patients with knee OA. However, more
adequately powered and higher-quality clinical trials are needed to
further confirm these conclusions.
Subsequent clinical trials assessing the efficacy of low-intensity
ultrasound intervention on OA have come to similar conclusions.
A small trial was conducted with 12 OA patients who had been
diagnosed with OA for an average of 5 years [32]. Continuous
ultrasonic waves (1MHz frequency, 0.8W/cm2 power with a 5-cm
diameter applicator) were applied to the medial and lateral parts of
the knee for 3-4 minutes, 2 days/week, for 12 weeks. Patients reported
reduced disability, according to the WOMAC scores (decrease from
53.5 ± 12.2 to 28.8 ± 14.8, P=0.0002), and improved function, as
assessed by a six-minute walking test, after the ultrasound intervention
(mean improvement of 14.1 ± 22.5%, P=0.04), when compared to
assessments taken before ultrasound treatment [32].
Yang et al. conducted a clinical trial involving 100 OA patients,
who had been diagnosed with OA for an average of 2.8 years, and
subjected them to ultrasound or mock treatment [33]. The ultrasound
treatment (parameters were not reported) consisted of 15 minutes of
ultrasound application with three applicators which simultaneously
stimulated the lateral and medial compartments, and medial joint
space. Following 5 days of treatment, patients in the ultrasound group
reported lower VAS and Lequesne scores (VAS efficacy index, mean
= 0.3640, SD =0.28062, P = 0.000; Lequesne efficacy index, mean =
0.3080, SD = 0.42076, P = 0.000) [33].
A randomized, placebo-controlled double-blind study
investigated the short-term efficacy of ultrasound therapy in 90
OA patients [34]. Patients were randomly assigned to three groups:
continuous ultrasound (1 Mhz frequency and 2W/cm2 power with
a 5-cm diameter applicator) for 5 minutes, pulsed ultrasound (1
Mhz frequency and 2W/cm2 power with a pulsed mode duty cycle
of 1:4) for 5 minutes, or sham treatment for 5 minutes. Treatments
were applied once a day, 5 days/week for 2 weeks. At the end of the
study, patients in the pulsed ultrasound group showed the greatest
reduction in pain (from 6.89 ± 1.39 to 5.25 ± 1.90, VAS score, p<0.05)
and WOMAC score (from 43.43 ± 8.26 to 35.61 ± 8.73, p<0.05).
Furthermore, walking time in a 20-meter test was shortened most
significantly in the pulsed ultrasound group (from 22.57 ± 2.08 to
20.00 ± 1.94 seconds, p<0.05) [34].
The mechanisms mediating the symptom-modifying effects of
ultrasound on OA are not well established, largely because processes
linking pain with OA are not well understood [35]. Of notice, recent
evidence shows pro-inflammatory cytokines promote pain in OA
by interacting with other biological mediators [36]. For example,
pro-inflammatory cytokine interleukin (IL)-1β has been reported to
stimulate nociceptors directly through intracellular kinase activation,
and indirectly through the production of pro-inflammatory mediators
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including prostanoids [37]. Tumor necrosis factor (TNF)-α also has
been demonstrated to activate sensory neurons directly [37,38], and
anti-TNF-α treatment reduced OA-associated pain symptoms [39].
These mechanisms are of interest because LIPUS has been reported
to reduce the inflammatory activity of synovitis in vivo, which was
associated with a decrease in the number of cells expressing proinflammatory mediator cyclooxygenase 2 (COX-2) [40]. In vitro,
LIPUS reduced levels of IL-1 and TNF-α in rat Schwann cells [41].
Together, these studies suggest therapeutic ultrasound may alleviate
OA-associated pain by reducing inflammatory activity.

Potential for OA-Disease Modification
While recent clinical studies provide evidence that supports
ultrasound exerting OA-symptom modifying effects, it is not
clear whether ultrasound exerts effects on disease-modification,
such as arresting or slowing OA disease progression. Interestingly,
recent preliminary evidence suggests ultrasound may be used for
chondroprotection by enhancing anabolic activity, suppressing
catabolic activity, preventing chondrocyte apoptosis, and altering
obesity-related inflammatory metabolism.
The anabolic effect of ultrasound has been previously
demonstrated in small animal studies. In New Zealand rabbits
with full-thickness osteochondral defects, daily LIPUS treatment
significantly improved the morphologic features and histologic
characteristics of the repaired cartilage [42,43]. Subsequent studies
in a canine model further demonstrated a positive effect of LIPUS
treatment on cartilage repair [44]. In an in vitro 3D agarose gel culture
model, LIPUS stimulated aggrecan and type II collagen synthesis but
did not affect the proliferation of human chondrocytes [45]. Results
from an in vitro 3D alginate bead model showed LIPUS increased the
number and size of glycosaminoglycan-positive lacunae and cellular
organelles in human chondrocytes [46].
Ultrasound has also been reported to reduce catabolic activity
in chondrocytes. In OA joints, proteolytic enzymes, such as matrix
metalloproteinases (MMPs)-1, -3, -13, and ADAMTS (a disintegrin
like and metalloproteinase with thrombospondin type 1 motifs), are
overactivated. These enzymes directly cleave the cartilage matrix,
leading to a homeostatic imbalance and cartilage breakdown [47-49].
Ito et al. found in vitro, LIPUS (0 to 120 mW/cm2) reduced MMP13 expression in an intensity dependent manner, with the greatest
decrease seen at 120 mW/cm2 [50]. The authors also reported LIPUS
downregulated expression of MMP-3 and MMP-13 in porcine
cartilage explants [50]. Li et al. assessed the efficacy of LIPUS on
preventing OA in a surgically-induced model (transaction of the
anterior cruciate ligament) in rabbits [51]. Immediately after surgery,
animals were treated with LIPUS at 3 MHz, 20% duty cycle, 40 mW/
cm2 for 20 minutes/day, 6 days/week, for 6 weeks. Sham-treated
animals were handled in the same manner as the LIPUS group, but
not subject to ultrasound. At six-weeks following treatment, it appears
that LIPUS exerted an OA disease modification effect, because LIPUStreated animals had a significantly lower histopathological cartilage
score compared to sham-treated animals (sham treatment: 10.33
± 2.66, ultrasound treatment: 6.67 ± 1.21, P<0.05, Mankin grading
system). Consistent with this observation, a reduced level of MMP13 was also observed in the cartilage of LIPUS-treated animals [51].
In osteoarthritis, the fate and function of chondrocytes is altered,
as evidenced by their abnormal proliferation, senescence, and cell
death [4,52]. In a study to determine whether ultrasound can be used
J Surgery 1(2): 5 (2013)

to prevent chondrocyte apoptosis in OA, OA was first surgicallyinduced in rabbits using the anterior cruciate ligament transaction
model [53]. For the experiment, LIPUS was applied at six weeks
following surgery, at an intensity of 300 mW/cm2 at 1 MHz, 20% duty
cycle for 10 minutes/day for 2 weeks. At the end of the ultrasound
treatment, microscopic morphologic grading showed the ultrasoundtreated group had a significantly lower OA score compared to
untreated controls (control: 2.75 ± 0.50, ultrasound-treated: 1.67
± 0.52, P=0.002). There was also a trend for a lower percentage of
apoptotic chondrocytes in animals treated with LIPUS, although the
difference was not significant [53].

Adipose Modification and Chondroprotection
Obesity is one of the risk factors for OA initiation and disease
progression [54]. Studies suggest that obesity contributes to OA
through mechanical overloading and metabolic alteration [55].
Excessive adipose tissue increases mechanical stresses on weightbearing joints and generates an imbalance in the secretory profile of
adipokines, including leptin, adiponectin, visfatin, and resistin [56].
Together, such conditions create a low-grade systemic inflammation,
as evidenced by a significant increase, as much as 10-fold, in the levels
of pro-inflammatory cytokines IL-1β, IL-6, and TNF-α [57,58]. These
pro-inflammatory cytokines can then in turn upregulate expression
of MMPs and ADAMTS, leading to cartilage breakdown [59].
Randomized controlled clinical trials show weight loss is
associated with reductions in knee OA pain, increased mobility and
physical function [60,61]. Evidence shows each pound of weight lost
results in a 4-fold reduction in the compressive forces through the
load-bearing joints [62]; losing less than 5% body weight results in
some joint pain relief, while moderate to large clinical improvements
in joint pain are observed with at least 10% reductions in body weight
[63].
Although the efficacy of ultrasound in osteoarthritis has not
been studied in the context of obesity, recent studies suggest highintensity focused ultrasound (HIFU) is an effective method for
breaking down fat cells [64-66]. HIFU is delivered through the skin
and ultrasound energy absorption within the focal zone induces
high temperatures at the focal point, causing coagulative necrosis
and almost instantaneous cell death [67]. After the treated adipose
tissue is destroyed, chemotatic signals activate the body’s normal
inflammatory response mechanisms. Macrophage cells engulf the
lipids and cellular debris, and they are cleared via the lymphatic
system, leading to a reduction in adipose tissue [64]. Taken together,
by targeting adipose tissue, ultrasound may exert chondroprotection
by both directly reducing mechanical overloading stress, and
rebalancing the altered inflammatory metabolism.

Perspectives and Conclusion
Therapeutic ultrasound is widely used for various musculoskeletal
disorders, but its use for osteoarthritis treatment is still limited. Recent
clinical trials suggest ultrasound improves OA-associated symptoms,
including pain and joint dysfunction. However, well-designed and
higher powered clinical studies are needed to confirm these effects.
Furthermore, while disease-modifying effects of ultrasound have not
been reported in OA patients, supportive data from in vitro and in vivo
studies suggest a chondroprotective role of ultrasound, which includes
enhancing anabolic activity, lowering levels of catabolic activity, and
preventing apoptosis in chondrocytes. In addition, adipose tissue,
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Figure 1: Ultrasound as a potential intervention for OA symptom- and
disease-modification. Recent clinical evidence suggests therapeutic
ultrasound (TU) relieves OA-associated pain and improves function, which
may be mediated by the anti-inflammatory effects of ultrasound. In vitro and
in vivo studies show therapeutic ultrasound reduces catabolic activity and
apoptosis in chondrocytes, and high-intensity ultrasound (HIFU) ablates
fat tissue and modulates adipokines, which together, may exert diseasemodifying effects in OA.

which creates an inflammatory endocrine environment and may be a
driver of OA initiation and progression, can be targeted by ultrasound
(e.g. high-intensity focused ultrasound). Collectively, we propose
ultrasound as a potential intervention for OA symptom- and diseasemodification (Figure 1). In summary, therapeutic ultrasound may
exert effects not only on symptom-modification but also has a strong
potential for chondroprotection and disease-modification in OA. A
better understanding of the mechanistic actions of ultrasound may
transform ultrasound into a highly effective, non-invasive modality
for osteoarthritis prevention and treatment.
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